Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 26;10(1):514.
doi: 10.1186/s13104-017-2840-1.

A first description of the Colombian national registry for rare diseases

Affiliations

A first description of the Colombian national registry for rare diseases

Heidi Eliana Mateus et al. BMC Res Notes. .

Abstract

Objective: Orphan diseases must be considered a public health concern, underlying country-specific challenges for their accurate and opportune diagnosis, classification and management. Orphan disease registries have not yet been created in South America, a continent having a population of ~ 415 million inhabitants. In Colombia ~ 3 million of patients are affected by rare diseases. The aim of the present study was to establish the first Colombian national registry for rare diseases. The registry was created after the establishment of laws promoting the development of clinical guidelines for diagnosis, management, census and registry of patients suffering rare diseases.

Results: In total, 13,215 patients were recorded in the Colombian registry. The survey reported 653 rare diseases. The most common diseases were congenital factor VIII deficiency (hemophilia A) (8.5%), myasthenia gravis (6.4%), von Willebrand disease (5.9%), short stature due to growth hormone qualitative anomaly (4.2%), bronchopulmonary dysplasia (3.9%) and cystic fibrosis (3.2%). Although, a marked under-reporting of cases was observed, some pathologies displayed similar behavior to that reported by other initiatives and databases. The data currently available in the registry provides a baseline for improvement regarding local and regional surveys and the start for better understanding rare diseases in Colombia.

Keywords: Colombian health system; Orphan disease; Rare disease registry.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Prevalence of rare diseases in Colombia. Data corresponds to all living patients affected by rare diseases registered in the health care provider’s system (2015)

References

    1. Schieppati A, Henter J-I, Daina E, Aperia A. Why rare diseases are an important medical and social issue. Lancet (London, England) 2008;371:2039–2041. doi: 10.1016/S0140-6736(08)60872-7. - DOI - PubMed
    1. Rubinstein YR, Groft SC, Bartek R, Brown K, Christensen RA, Collier E, et al. Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB) Contemp Clin Trials. 2010;31:394–404. doi: 10.1016/j.cct.2010.06.007. - DOI - PMC - PubMed
    1. Taruscio D, Capozzoli F, Frank C. Rare diseases and orphan drugs. Ann dell’Istituto Super di sanità. 2011;47:83–93. - PubMed
    1. Kodra Y, Fantini B, Taruscio D. Classification and codification of rare diseases. J Clin Epidemiol. 2012;65:1026–1027. doi: 10.1016/j.jclinepi.2012.02.014. - DOI - PubMed
    1. Montserrat Moliner A, Waligóra J. The European Union policy in the field of rare diseases. Public Health Genom. 2013;16:268–277. doi: 10.1159/000355930. - DOI - PubMed